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AP-1 activated protein 1 
APC antigen presenting cell 
Cbl casitas B-lineage lymphoma 
Cbp Csk binding protein 
CD cluster of differentiation 
Csk C-terminal Src kinase 
ERK extracellular signal regulated kinase 
GAP GTPase activating protein 
GEF guanine nucleotide exchange factor 
Grb2 growth factor receptor bound protein 2 
IKK IțB kinase 
IL-2 interleukin 2 
IS immunological synapse
ITAM immunoreceptor tyrosine based activation motif 
kd knockdown
LAT linker for activation of T cells 
Lck lymphocyte-specific protein-tyrosine kinase 
LIME Lck interacting membrane protein 
MAPK mitogen activated protein kinase 
MHC major histocompatibility complex 
NFAT nuclear factor of activated T cells 
NFțB nuclear factor țB
PAG phosphoprotein associated with glycosphingolipid enriched microdomains 
PI3K phosphatidylinositol 3 kinase 
PKC protein kinase C 
PLC phospholipase C 
PKR protein kinase RNA 
Ras rat sarcoma 
SFK Src family kinase 
SH Src homology 
SHP-1 SH2 domain containing protein tyrosine phosphatase 1 
SLP-76 SH2 domain containing leukocyte protein of 76 kD 
SOS son of sevenless 
Src sarcoma (from Rous sarcoma) 
TCR T cell receptor 
ZAP-70 ȗ -chain-associated protein of 70 kD 
7
2. List of publications included 
Paper I Methi T, Ngai J, Mahic M, Amarzguioui M, Vang T and Taskén K.  
Short-interfering RNA-mediated Lck knockdown results in augmented 
downstream T cell responses. 
Journal of Immunology 2005, 175:7398-7406. 
Paper II Methi T, Ngai J, Vang T, Torgersen KM and Taskén K.
Hypophosphorylated TCR/CD3-zeta signals through a Grb2-SOS1-Ras 
pathway in Lck knockdown cells. 
European Journal of Immunology 2007, 37:2539-2548. 
Paper III Methi T, Torunn Berge, Torgersen KM and Taskén K.  
Reduced Cbl phosphorylation and CD3-zeta degradation  
in T cells with low Lck levels.  
Manuscript submitted. 
Paper IV Ngai J, Methi T, Andressen KW, Levy FO, Torgersen KM, Vang T, 
Wettschureck N and Taskén K.





We have targeted Lck with siRNA-mediated RNA interference and investigated signaling 
properties in T cells with Lck knockdown. Proximal signaling was reduced in Lck-kd cells, 
as determined by overall tyrosine phosphorylation, CD3ȗ phosphorylation and Ca2+
mobilization. Despite this, NFAT-AP-1 activation and IL-2 secretion was increased (Paper 
I). We found that Grb2-SOS1 was recruited to hypophosphorylated CD3-zeta in these cells, 
leading to sustained Ras-Raf-1-ERK1/2 activation (Paper II). Furthermore, endocytosed 
TCR/CD3-containing vesicles were not targeted to lysosomes, and CD3-zeta levels 
remained elevated in Lck-kd cells (Paper III). This indicates that prolonged survival of 
internalized TCR/CD3-complexes may lead to sustained signaling through the Grb2-SOS1-
Ras-ERK pathway. If allowed to operate in the absence of negative feedback mediated by 
SHP-1 (Paper I), Ras-GAP (Paper II), and c-Cbl (Paper III) Lck-kd may thus result in 
hyperresponsive signaling in T cells with low Lck levels.
We have also investigated the involvement of G proteins in TCR-mediated immune 
responses, and the possible interplay between GĮq and Lck (Paper IV). TCR engagement 
activated GĮq and GĮs but not GĮi-2. Targeting of GĮs, GĮi-2 and GĮq using siRNA-
mediated knockdown demonstrated a specific role of GĮq in T cell activation with an 
increase in the transcriptional activation of NFAT-AP1, despite reduced proximal signaling. 
The same was found in primary T cells from GĮq deficient mice which displayed 
hyperproduction of IL-2, but a reduced ability to activate proximal signaling events. 
3. Introduction 
3.1. The immune system 
The human body is under constant attack from infectious agents such as viruses, bacteria, 
fungi, protozoa and parasites, and many mechanisms have evolved to protect us against 
these threats. Very few infectious agents can penetrate the barrier of intact skin, but the 
epithelia and mucus membranes of the nasopharynx, lungs, gastrointestinal and urogenital 
tracts are more vulnerable to entry. Microorganisms come in many different forms, and they 
continually change structure and strategy to breach or evade our first line defences. When 
infectious agents gain access to the body, they may cause disease, which can be fatal if left 
unchecked. A flexible immune response is therefore required to deal with the large variety 
of microorganisms. Recognition of pathogens is essential for the immune system, and 
especially separation from self and harmless material. The two main categories of pathogen 
recognition are the innate (non-adaptive) and adaptive immune responses. The former 
employs a fixed set of  mechanisms which have co-evolved with emerging microbes, and 
detect classical patterns in foreign material, such as bacterial carbohydrates 
(lipopolysaccharide), nucleic acids (bacterial or viral DNA or RNA) and peptidoglycans. In 
the adaptive immune response, T and B lymphocytes are responsible for specific immune 
recognition. T cells regulate, direct or execute immune effector functions, and are the 
subject of the next chapter. B cells produce antibodies. The hallmark of adaptive immunity 
is a custom tailored response to each microorganism. The response is therefore slower in 
onset but more potent than innate immunity. The adaptability of the system is achieved by 
somatic mutations and irreversible recombination of antigen receptor gene segments. These 
mechanisms allow a small number of genes to generate a vast number of different antigen 
receptors, which are then expressed on individual lymphocytes. Lymphocytes with self-
reacting receptors are eliminated, and the body thereby generates a receptor repertoire for 
essentially all antigens that are non-self. Triggering of a particular receptor gives rise to 
clonal selection and proliferation of the lymphocyte, and because the gene rearrangements 
have lead to an irreversible change in the DNA of each cell, all of the progeny will inherit 
genes encoding the same receptor specificity. This includes the T and B memory cells which 
are keys to long-lived specific immunity. 
3.2. T cells 
The main classes of T cells are the CD4+ helper (Th), CD8+ cytotoxic (Tc) and FOXP3+ 
regulatory (Treg) cells. All T cells develop from lymphoid bone marrow progenitor cells 
and are educated in the thymus. Naïve T cells migrate through lymph nodes, spleen and 
other secondary lymphoid organs, ready to be activated by the interaction with professional 
antigen presenting cells (APCs), such as macrophages, B cells and dendritic cells. CD4+ T 
cells regulate and direct cytotoxic (Th1) or humoral (Th2) immune responses depending on 
the type of infection encountered. The former is typically mounted against virus infections 
and cancer cells, whereas the latter targets bacterial and protozoan infections. The Th1 and 
Th2 responses are characterized mainly by the profile of cytokines produced, which in turn 
activate specific subsets of immune cells. The Th1 response involves IFNȖ, TNF and IL-2, 
and triggers cell-mediated inflammatory reactions executed by NK cells, macrophages and 
Tc cells. Tc cells eliminate virus infected cells and cancer cells through direct intervention 
10
after recognition of foreign antigen presented on MHC class I molecules. The Th2 response 
involves IL-4, IL-5, IL-10 and IL-13, and activate B cells. B cells produce and secrete 
antibody molecules, which bind infectious material and mark it for destruction. Tregs 
suppress immune responses after an infection has been purged, and thereby maintain 
immune system homeostasis and tolerance to self. Aberrant or disturbed activation of T 
cells may lead to autoimmune diseases or immunodeficiency.  
3.3. T cell receptor signaling 
The T cell receptor (TCR) complex 
consists of the heterodimeric Įȕ
chains and a  set of six polypeptides, 
the CD3 chains, designated Ȗİ ȗȗ įİ
(Fig.1). APCs continously process 
exogenous peptides and present them 
on MHC class II molecules. The TCR 
interacts with peptide-loaded MHC 
class II molecules but will only be 
engaged with sufficient strength if 
there are matching antigen epitopes 
present (Reviewed in Kuhns et al. 
2006, and Rudolph et al., 2006). Many 
factors are involved in proper 
activation of T cells. The strength and 
duration of the TCR-MHC class II engagement is important, but also the presence of a co-
stimulatory signal mediated through CD28. CD28 interaction with B7 proteins on APCs 
ensures that the TCR is engaged by professional immune cells, and not  accidentally by 
other cells or by soluble antigen. Absence of a secondary CD28 signal will lead to T cell 
anergy, a state characterized by a lack of T cell responsiveness to otherwise effective 
antigens. Anergy has emerged as a fundamental mechanism for preventing autoimmune 
responses to self-antigens. 
Figure 1. The TCR/CD3-complex 
The TCR is located in specialized plasma membrane microdomains, termed lipid rafts. 
Lipid rafts consist of cholesterol and sphingolipid-enriched platforms which segregate 
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various signaling molecules, and are postulated to function in signaling and membrane 
trafficking (Ilangumaran et al., 2000; Marmor and Julius, 2001; Harder, 2001; Horejsi, 
2003). The immunological synapse is a term used to denote the complex array of protein-
protein interactions which arises between a T cell and an APC (Monks et al. 1998; Grakoui 
et al., 1999; Reviewed in Dustin et al., 2005). The formation and organization of an 
immunological synapse is constituted by the coalescence of lipid rafts and recruitment of 
signaling proteins, the binding of integrins and adhesion molecules, as well as the TCR-
MHC class II and CD28-B7 contacts. Altogether, this platform relays coordinated signals 
from the exterior to the interior of the T cell. Intracellular TCR signaling will be elaborated 
in the following chapters. Briefly summarized, Lck becomes activated upon TCR 
engagement, and phosphorylates the intracellular portions of the TCR/CD3-complex. ZAP-
70 binds and phosphorylates LAT, to which many adaptor and effector proteins are 
recruited. This culminates with the mobilization of intracellular Ca2+ and activation of PKC 
and Ras. In turn, transcription factors translocate to the nucleus of the T cell. Activated T 
cells secrete a plethora of cytokines which lead to proliferation and differentiation of 
immune cells. 
3.4. Lck and Src family kinases 
The most membrane proximal event to take place after engagement of the TCR is the 
activation of Lck (Lymphocyte specific tyrosine kinase). Lck is a 509 amino acids long, 56-
kD nonreceptor protein-tyrosine kinase of the Src oncogene family. The Src family of 
kinases (SFKs) also contain the members Src, Yes, Fyn, Lyn, Hck, Fgr and Blk, but only 
Lck, Fyn and Yes are expressed in T cells (Kitamura et al., 1982; Marth et al., 1985; 
Voronova and Sefton, 1986; Semba et al., 1986; Cooke and Perlmutter 1989; Olszowy et al., 
1995). The SFKs share many structural and functional features of Lck, and since Lck is is 
the main topic of this thesis, it will serve as a model example of a Src kinase in the 
following presentation. 
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3.4.1 Structure of Lck 
Lck is composed of SH3, SH2 and SH1 domains 
arranged sequentially from the N-terminus to the C-
terminus (see Fig. 2). The SH3 domain is 57 residues 
long and interact with proline rich regions with a 
central PXXP motif (Cohen et al., 1995). The SH2 
domain is 91 residues long and interacts with certain 
phospho-tyrosines (the Src SH2 domain prefer the 
sequence pYEEI/L) (Cohen et al., 1995; Pawson, 
1995). The SH1 domain is a 250 residue-long tyrosine kinase. Although Fyn and Lck both 
have SH2 and SH3 domains, the binding specificities of these domains are significantly 
different, and confer unique functions to these SFKs in T cell signaling (Lin et al., 2000; and 
reviewed in Zamoyska et al., 2003). Lck functions primarily as a tyrosine kinase, but both 
the SH2 (Straus et al., 1996; Lewis et al., 1997) and the SH3 domain (Denny et al., 1999) 
have been shown to be important for signaling in T cells. 
Figure 2. Lck 
Lck is anchored to the plasma membrane through lipid modifications (Marchildon et al., 
1984; Marth et al., 1985, Voronova and Sefton, 1986). The N-terminal residues G2 and 
C3/5 are myristoylated and palmitoylated respectively (Marchildon et al., 1984; Johnson et 
al., 1994, Paige et al., 1993; Koegl et al., 1994; Yurchak et al., 1995). Fyn also contains 
lipid anchors, but the localizations of Lck and Fyn are non-overlapping in T cells, 
suggesting spatial organization by other mechanisms (Ley et al., 1994; Lin et al., 2000; 
Filipp et al., 2003; Filipp et al. 2004). Lck interacts with two cysteines within an CXCP 
motif in the intracellular domains of CD4 and CD8 through a unique SH4 domain in a zinc-
dependent manner (Veillette et al., 1988; Rudd, et al., 1988; Rudd et al., 1989; Luo and 
Sefton, 1990; Turner et al., 1990; Kim et al., 2003). Approximately 50% of Lck in T cells 
interact with CD4 in this way (Veillette et al., 1988), and since CD4 is normally excluded 
from lipid rafts, so is Lck. In fact, up to 95% of Lck to resides in soluble membrane 
fractions, whereas more than 98% of Fyn concentrates within lipid rafts, some of which 
associates with the TCR/CD3-complex (Samelson et al., 1990; Timson Gauen et al., 1992; 
Filipp et al., 2003). There is some controversy in the field regarding Lck and lipid raft 
translocation. It has been reported that a large fraction of Lck resides in lipid rafts even in 
resting cells, and that CD28 but not CD4 stimulation results in more Lck recruitment into 
rafts (Tavano et al., 2004). 
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3.4.2. Lck and Fyn in T cell development 
Lck is primarily expressed in T cells where it serves many functions, both in signaling and T 
cell ontogeny. TCR signaling affects the selection and survival of T cells at every stage of 
development (Shortman and Wu, 1996, Sebzda et al., 1999; Kruisbeek et al., 2000). Lck 
knockout mice display thymic atrophy and diminished double positive (CD4+CD8+) 
thymocytes (Molina et al., 1992). Mature, single positive thymocytes could not be detected 
in these animals and peripheral T cell counts were very low Similar findings have been 
reported with transgenic mice expressing a dominant-negative version of Lck (Levin et al., 
1993). This underscores an important role of Lck in T cell development for which Fyn can 
not compensate. Thymocytes from Fyn-deficient mice undergo normal maturation (Stein et 
al., 1992; Appleby et al., 1992). However, Fyn is not completely dispensable since knockout 
of both Lck and Fyn leads to a complete arrest in T cell development at the double negative 
(CD4-CD8-) thymocyte stage (van Oers et al., 1996a; Groves et al., 1996). 
3.4.3. Regulation of Lck by phosphorylation and dephosphorylation 
Lck is phosphorylated on two main residues, Y394 (Marth et al., 1988; Veillette et al., 
1989a; Veillette et al., 1989b; Lou and Sefton, 1990; Abraham and Veillette, 1990) and 
Y505 (Courtneidge, 1985; Cooper et al., 1986; Cooper and King, 1986; Amrein and Sefton, 
1988;  MacAuley and Cooper, 1989). The former is an autophosphorylation site which leads 
to 2-4 fold increased tyrosine kinase activity. The latter is phosphorylated by C-terminal Src 
Kinase (Csk) which inhibits Lck (Okada and Nakagawa 1989; Thomas et al., 1991; Nada et 
al., 1991; Okada et al., 1991; Bergman et al., 1992). Phosphorylated Y505 interacts with the 
intrinsic SH2 domain of Lck, thus folding the protein onto itself. This inhibits the kinase 
domain indirectly by inducing conformational changes in the catalytic site (Yamaguchi and 
Hendrickson, 1996; Sischeri et al., 1997; Xu et al., 1997; Xu et al., 1999). pY394 is 
dephosphorylated primarily by the PTPases SHP-1, CD45 and LYP (Wu et al., 2006), 
wheras pY505 is dephosphorylated mainly by CD45. SHP-1 is a central negative regulator 
of T cell signaling and is presented in chapter 3.7.2. CD45 is expressed in all nucleated 
hematopoietic cells, but not in other cell types (Mustelin et al., 1989; Mustelin et al., 1990; 
Mustelin et al., 1992). In CD45-deficient lymphocytes both Lck and Fyn are 
hyperphosphorylated on Y505 and Y528 respectively, and these cells show diminished 
responses to antigen stimulation (Pingel and Thomas 1989; Ostergaard et al., 1989; 
Koretzky et al., 1990; Kishihara et al., 1993; Stone et al., 1997). Membrane targeting or 
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overexpression of Csk is sufficient to inhibit TCR induced phosphorylation and IL-2 
production through phosphorylation of Y505 (Chow et al., 1993). In contrast, deletion or 
mutation of Y505 in Lck results in a constitutively active enzyme (Marth et al., 1988; 
Abraham et al., 1991; Chow et al., 1993). Dephosphorylation of pY505 is therefore thought 
to be a critical positive regulator of Lck and Fyn in T cells. Lck is also phosphorylated on 
S59 (Winkler et al., 1993), and this regulates the specificity of the SH2 domain (Joung et al., 
1995). Weak TCR ligands may trigger a negative feedback loop dependent on the 
recruitment of SHP-1 to Lck. This is prevented when stronger ligands bind though ERK-
dependent phosphorylation of S59 in Lck (Stefanova et al., 2003). Phosphorylation of Y192 
within the SH2 domain of Lck disrupts SH2 binding, thereby negatively regulating its 
participation in T cell antigen receptor signaling (Couture et al., 1996). 
3.4.4. Activation and function of Lck 
The TCR/CD3-complex lacks enzymatic activity and is therefore dependent on external 
kinase activity for signal transmission. Lck is considered to be the principal mediator of this 
function (Veillette et al., 1989a; Veillette et al., 1989b; Veillette et al., 1989c; Barber et al., 
1989; Abraham et al., 1991; Luo and Sefton, 1992). However, the exact nature of how Lck 
becomes activated after engagement of the TCR is still elusive. Several mechanisms have 
been proposed: Release from tonic inhibition bt Csk, dephosphorylation of the inhibitory 
pY505 by CD45, clustering within the immunological synapse and juxtaposition of Lck 
with the TCR/CD3-complex through CD4-Lck interaction with MHC class II molecules. 
Other forms of SFK activation have also been described. For example, it has been shown 
that engagement of the SH3 domain of Lck by a proline-rich sequence in CD28 increases 
the phosphotransferase activity of Lck (Holdorf et al., 1999). Furthermore, engagement of 
the IL-2 receptor increases the activity of bound Lck (Horak et al., 1991), although IL-2 
signaling is not dependent on Lck (Karnitz et al., 1992). In fact, T cells from Lck -/- mice 
exibit enhanced proliferative responses to IL-2 stimulation (Molina et al., 1992). Src 
interaction with small G proteins is discussed in chapter 3.8., and examined in more detail in 
Paper IV. The kinetics and discrete regulation of Y394 and Y505 dephosphorylation by 
CD45 is not fully elucidated, and it is likely that CD45 has a role as both positive and 
negative regulator of T cell signaling, which is underscored by recent data (McNeill 2007). 
It has also been reported that CD4-Lck clusters outside the immunological synapse, away 
from the TCR-CD3 complex (Ehrlich et al., 2002). Furthermore, stimulation with anti-CD3İ
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antibodies (OKT3) is sufficient to trigger robust Lck activation in Jurkat and primary T 
cells, but the link between CD3İ engagement and Lck activation is still unknown. 
Although different mechanisms of activation exist, it is evident that Lck becomes activated 
upon TCR engagement. The main substrates for Lck are the CD3-chains of the TCR-
complex (Barber et al. 1989), and several lines of evidence suggest a pivotal role for Lck in 
signal transmission through the TCR. Pharmacological inhibition of Lck and Fyn with PP2, 
or new specific Lck inhibitors, abolish anti-CD3-induced T cell signaling (Hanke et al., 
1996; Rapecki et al., 2002). The Jurkat cell line JCaM1, which is deficient in Lck, does not 
respond to anti-CD3 engagement, and reconstitution of these cells with Lck restores T cell 
signaling (Goldsmith and Weiss, 1987; Straus and Weiss, 1992). Fyn may also 
phosphorylate the TCR/CD3-complex, but overexpression of Fyn in JCaM1 cells only leads 
to a partial recovery (Denny et al., 2000). On the other hand, it has been shown that Syk is 
activated independently of Lck upon CD3-stimulation (Couture et al., 1994; Chu et al., 
1996), and reconstitution of JCaM1 cells with Syk, but not ZAP-70, could also restore 
signaling to ERK (Williams et al., 1997).  Knockout mice have been generated for both Lck 
and Fyn, and data from these animals indicate that Lck is important, but not indispensible 
for the TCR/CD3 signaling pathway. The proliferative response to anti-CD3 or TCRĮȕ
crosslinking was substantially reduced in Lck -/- T cells, but was still higher than in 
unstimulated cells (Molina et al., 1992). Phosphorylation of CD3ȗ and ZAP-70 was virtually 
absent in murine Lck -/- thymocytes, but several phosphoproteins were induced, although to 
a lower degree and with slower kinetics than in wild-type cells (van Oers et al., 1996b). 
TCR engagement resulted in CD69 expression in Lck deficient mice, albeit to a 
substantially lower level than in control animals. Furthermore, peripheral T cells from Lck -
/- mice showed normal responsiveness to allostimulation (allo-MHC antigens), suggesting 
that Lck is not required for this T cell effector function (Yamada et al., 1997). A major 
problem with Lck knockout animals is that compensatory mechanisms may have developed, 
and that the few T cells that do mature may represent a population that has adapted to the 
loss of Lck. Lck–/– mice may therefore not be the best model to investigate all aspects of Lck 
signaling in vivo, and conditional transgenic mice (Lck1ind) that express Lck by a T cell-
specific tet-inducible mechanism have been developed. This model has reveled a central role 
for Lck in the differentiation of CD4 and CD8  thymocytes, but no detectable change in T 
cell numbers in peripheral lymphoid organs was observed even 9 weeks after loss of Lck 
(Legname et al., 2000; Tewari et al., 2006). Interestingly, it has been shown that the absence 
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of Lck actually increased the long-term survival of naïve T cells (Seddon et al., 2000), and 
that Lck expression was not essential for responses of memory CD8+ T cells to secondary 
antigen stimulation in vivo or in vitro (Tewari et al., 2006). One report has used mice 
expressing a Lck transgene in the thymus to overcome the developmental block associated
with the Lck–/– background (Trobridge and Levin 2001). It was shown that primary Lck–/– T 
cells from these animals had an impaired Ca2+ mobilization and defective proliferation.
However, the authors also showed that T cells expressing an excess of a catalytically 
inactive Lck were capable of inducing Ca2+-fluxes, suggesting that Lck kinase activity is not 
essential in T cell activation. TCR signaling in Lck1ind mice with or without the Fyn -/-
background has recently been investigated (Lovatt et al., 2006). In this system, T cells with 
low levels or complete absence of Lck was compared to wild-type cells. It was shown that 
Lck controls the threshold of T cell activation by specifically activating the CD3ȗ-ZAP-70-
LAT-PLCȖ1-pathway, leading to Ca2+ dependent induction of IL-2 synthesis. Surprisingly, 
crosslinking CD4 with the TCR enhanced signal transduction even in the absence of Lck, 
resulting in Ca2+ flux and phosphorylation of some LAT residues in Lck-deficient T cells. 
This occured without  ZAP-70 or PLCȖ1 phosphorylation. Furthermore, the activation of
MEK and ERK was surprisingly high in Lck-low or Lck-deficient mice, although reduced 
compared to wild type animals. Fyn was shown to be responsible for these effects, and the 
authors concluded that Lck and Fyn target the ERK1/2-pathway through distinct Ras 
activators. Interestingly, when intracellular IL-2 was visualized, a significant proportion of
Lck-deficient cells were found to produce IL-2 even though secretion was reduced. This 
indicates that signals received in the absence of Lck are sufficient to open the IL-2 locus but 
insufficient to induce normal levels of IL-2 secretion. Work included in this thesis 
investigate further how low levels of Lck may result in T cell signaling (Paper I and II). 
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3.4.5 Summary of Lck interaction partners and/or substrates 
Table 1. Lck interaction partners and/or substrates 
Protein Reference
Cbl I Rao et al., 2002, Hawash et al., 2002 
CD28 I Holdorf et al., 1999 
CD3ȗ/İ/Ȗ/į S Barber et al., 1989, Straus and Weiss 1992, van Oers 1996b 
Ezrin S Autero et al., 2003 
Fyn S Filipp et al., 2003 
IL-2 receptor I/S Hatakeyama et al., 1991, Delespine-Carmagnat 1999 
Itk S Heyeck et al., 1997 
LAT S Jiang and Cheng, 2007 
LIME I/S Brdickova et al., 2003, Hur et al., 2003 
PKCį/ș S Konishi et al., 2001, Liu et al., 2000 
PLCȖ1 S Liao et al., 1993 
Ras-GAP S/I Amrein et al., 1992, Amrein et al., 1994 
Shc S/I Walk et al., 1998, Fukushima et al., 2005 
SHP-1 S/I Lorenz et al., 1994 
Unc119 I Gorska et al., 2004 
Vav1 S Gulbins et al., 1993 
ZAP-70 S/I Duplay et al., 1994, Pelosi et al., 1999 
I = Interaction partner; S=Substrate 
3.4.6 Fyn 
Fyn has been shown to be important for signal transduction in T cells (Cooke et al., 1991; 
Tsygankov et al., 1992). Peripheral T cells from Fyn -/- animals display relatively normal 
proliferative responses, but have blunted Ca2+ mobilization and IL-2 production (Stein et al., 
1992; Appleby et al., 1992). Although Fyn plays a role in T cell signaling, it does not have 
the same impact as Lck, since overexpression of Fyn can not fully substitute for the loss of 
Lck (Denny et al., 2000). It has been shown that Fyn requires Lck recruitment to lipid rafts 
for its activation, and Fyn thus appears to be dependent on and function subsequently to Lck 
upon TCR engagement (Filipp et al., 2003; Filipp et al., 2004). Some lines of evidence have 
suggested that one of the roles of Fyn is to dampen T-cell responses, while Lck acts to 
amplify them (Lovatt et al., 2006; Filby et al., 2007). Fyn provides incomplete signals, such 
as those delivered by antagonistic ligands (Utting et al., 1998), and Fyn interacts specifically 
with some negative regulators of T-cell activation, such as c-Cbl (Tsygankov et al., 1996; 
see chapter 3.7.4.) and Cbp/PAG (Yasuda et al., 2002). Cbp/PAG is a transmembrane 
protein which binds Csk when phosphorylated (Brdicka et al., 2000; Kawabuchi et al., 
2000). TCR stimulation leads to transient dephosphorylation of Cbp/PAG, probably in a 
CD45-dependent manner, therby releasing Csk from its plasma membrane anchor, and thus 
facilitating T cell activation (Torgersen et al., 2001; Davidson et al., 2003). Fyn-mediated 
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rephosphorylation of Cbp/PAG leads to the recruitment of Csk, and thereby constitutes a 
negative feedback mechanism. The function of Cbp/PAG is, however, still under 
investigation. In contrast to Csk null mutation, which leads to embryonic lethality (Imaoto 
and Soriano, 1993; Nada et al., 1993), Cbp/PAG-deficient mice appear normal (Dobenecker 
et al., 2005; Xu et al., 2005). Dobenecker et al. reported that Csk was still recruited to lipid 
rafts in these animals, indicating that other Csk adaptors compensate for the loss of 
Cbp/PAG. On the other hand, Xu. et al. reported that raft localization of Csk was greatly 
reduced, but that this did not lead to any detectable functional defects in T cell signaling. A 
recent report showed that siRNA-mediated knockdown of Cbp/PAG enhanced SFK and Ras 
activation (Smida et al., 2007). It has also been shown that Fyn-dependent phosphorylation 
of Cbp/PAG is involved in the induction of anergy (Davidson et al., 2007). Other interaction 
partners of Fyn in T cell signaling are SAP/SLAM (Chan et al., 2003; Latour et al., 2003; 
Davidson et al., 2004), Fyb (Da Silva et al., 1997) and the focal adhesion kinase family 
(Kanazawa et al., 1996). Phosphorylation of Pyk2 links Fyn to cytoskeletal organization, 
cell spreading and migration (Qian et al., 1997) 
3.4.7. Lck and human pathophysiology 
Aberrant expression or regulation of Lck has been associated with several diseases. Some 
patients with systemic lupus erythematosus (SLE) have T cells with decreased levels of Lck 
due to increased ubiquitin-mediated degradation. The specific Lck activity, however, was 
increased, and the T cells displayed augmented apoptosis and lipid raft abnormalities 
(Matache et al., 1999; Matache et al., 2001; Jury et al., 2003).
Patients with common variable immunodeficiency (CVID) or severe combined immuno 
deficiency (SCID) have been reported to have reduced Lck levels (Goldman et al., 1998; 
Sawabe et al., 2001). In both patients it was shown that the lck transcript lacked the entire 
exon 7 resulting in reduced or almost complete loss of Lck expression. Interestingly, JCaM1 
cells exibit the exactly same defect, but the responsible mutation is yet to be found. 
Surprisingly, anti-CD3-induced tyrosine phosphorylation, ERK1/2 phosphorylation and 
calcium mobilization was intact in the SCID-patient, yet CD69 and most proliferative 
responses were reduced. However, the proliferative responses to allo-antigen were intact 
(Goldman et al., 1998) as reported previously (Yamada et al., 1997). Altogether, these 
studies indicate that loss of Lck can result in congenital immunodeficiency and selective 
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CD4 lymphopenia. This separates human T cell development from that of mice, since mice 
deficient in p56lck show a substantial reduction in CD4+/CD8+ thymocytes with the 
development of only a small number of peripheral single positive T cells (Molina et al., 
1992).
Lck is the target of many viral proteins, especially the tyrosine kinase interacting protein Tip 
of Herpesvirus saimiri (HVS), and Nef encoded by the Human immunodeficiency virus 
(HIV). The oncoprotein Tip physically interacts with Lck in HVS transformed cells, and 
augments Lck activity independently of Y394 and/or Y505 phosphorylation (Wiese et al., 
1996; Hartley et al., 1999). Tip induces peripheral T-cell lymphoma in transgenic mice 
(Wehner et al. 2001). Nef contributes to HIV disease pathogenesis by augmenting virus 
replication and disturbing T cell function. Nef binds and inhibits Lck, and MAPK kinase 
activity (Greenway et al., 1996), but simultaneous overexpression of Nef has been shown to 
increase T cell ERK1/2 phosphorylation in a calcium-independent manner (Schrager et al., 
2002). Furthermore, Nef synergizes with PMA in inducing NFAT activation, an effect that 
is independent of Lck (Manninen et al., 2002). According to these data it appears that the 
Ras pathway rather than the calcium pathway is the rate-limiting step in TCR-mediated 
NFAT induction. The suceptibility of T cells to HIV infection has been inversely correlated 
with Lck activity (Yousefi et al., 2003). HIV binds to CD4 through gp120 (Juszczak et al., 
1991), and internalization of gp120 is associated with down-modulation of membrane CD4 
and Lck together with impairment of T cell activation (Cefai et al., 1992). Reduced levels of 
Lck but increased levels of Fyn may play a role in the anergic response observed early 
during HIV infection (Cayota et al., 1994). 
Reduced Lck levels have also been shown in some type 1 diabetic patients. Interestingly, 
both ZAP-70 and PLCȖ1 recruitment and phosphorylation was relatively normal, despite 
reduced phosphorylation of CD3ȗ (Nervi et al., 2000). Furthermore, T cells from the 
synovial fluid of rheumatoid arthritis patients displayed lower levels of Lck protein, and 
components of the TCR/CD3-complex (Romagnoli et al., 2001). This downregulation 
correlated with hyporesponsiveness of the T cells. Lastly, Lck has also been shown to be 
downregulated in Alzheimer disease, and was identified as a risk gene for this disease 
(Zhong et al., 2005). 
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3.5. CD3 chain ITAMs 
Immunoreceptor tyrosine-based activation motifs (ITAMs) are 
found within the intracellular portions of the CD3 chains, and are 
the principal substrates for Lck in T cell signaling (Barber et al. 
1989; Irving et al., 1993, Iwoshima et al., 1994, van Oers et al., 
1996b). ITAMs have the concensus sequence YXXL/IX(6-
8)YXXL/I (Reth, 1989), and CD3ȗ contains three repititions of 
of this motif, whereas the  Ȗ, į and İ-chains contain only one 
(Reviewed in Pitcher et al., 2003, and Pitcher and van Oers, 
2003). Each doubly phosphorylated ITAM may recruit the 
tandem SH2 (Src homology 2) domains of ZAP-70 (Chan et al., 
1991; Wange et al., 1992; Wange et al., 1993; Iwashima et al., 
1994) (Fig. 3). ZAP-70 is a Syk family tyrosine kinase which is activated through 
phosphorylation by Lck on Y443 (Chan et al., 1995; Kong et al., 1996) and 
autophosphorylation on many sites, most importantly Y319 (Pelosi et al., 1999; Di Bartolo 
et al., 1999; Williams et al., 1999). The main substrate of ZAP-70 is the Linker for 
Activation of T cells (LAT) (Zhang et al., 1998) (see chapter 3.6). Loss of ZAP-70 disrupts 
TCR signaling and T cell development (Negishi et al., 1995; Williams et al., 1998), 
although ZAP-70-independent signaling has also been shown (Shan et al. 2001). 
Figure 3. CD3ȗ
In thymocytes and peripheral T cells, ITAMs are constitutively tyrosine phosphorylated on 
some residues (van Oers et al., 1993; van Oers et al.; 1994; Pitcher et al., 2003), and it 
appears that Lck or Fyn may fulfill the function of partly phosphorylating ITAMS in resting 
T cells equally well (Seddon and Zamoyska, 2002). ZAP-70 binds to these phosphorylated 
ITAMs but is not activated. Whether this pool of ZAP-70 transduces low level signals 
necessary for T cell survival, primes T cells for activation, or merely protects the ITAMs 
from other proteins, is currently unknown (reviewed in Zamoyska et al., 2003). 
Mutational analysis has revealed redundancy between various chains of the CD3 complex. 
CD3 Ȗİ/įİ provides normal T cell functions in the absence of CD3ȗ (Wegener et al., 1992; 
van Oers et al., 1998, Ardouin et al., 1999; van Oers et al., 2000), and TCR signaling is not 
qualitativly affected by crippling of the CD3İ ITAM (Sommers et al., 2000). The migration 
of unphosphorylated CD3ȗ is 16 kD, and depending on increasing tyrosine phosphorylation, 
21 and 23 kD forms also appear. The six tyrosine residues in ITAM1-3 are numbered Y1-6 
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counting from the N-terminal membrane proximal part. The kinetics of CD3ȗ
phosphorylation has been studied to great extent, with some conflicting findings. It is 
thought that a hierarchic pattern of phosphorylation exists, where phosphorylated ITAM2 
and 3 correspond to p21, whereas full phosphorylation correspons to p23 (Kersh et al., 
1998a; van Oers et al., 2000). Differential signaling occurs from truncated or tyrosine-to-
phenylalanine mutations in CD3ȗ ITAMs, and partially phosphorylated CD3ȗ can inhibit 
(Kersh et al., 1999), variably affect (Chae et al., 2004) or not affect (Ardouin et al., 1999) T 
cell activation. Some reports indicate that proteins such as Grb2, Shc and SOS may be 
recruited to hypophosphorylated ITAMs (Ravichandran et al., 1993; Osman et al., 1995; Nel 
et al., 1995; Labadia et al., 1996; Zenner et al., 1996; Chau and Madrenas 1999). This kind 
of signaling from CD3ȗ may be relevant under certain physiological settings, for example, it 
has been shown that various TCR binding affinities may mediate differential 
phosphorylation of the CD3ȗ chains, leading to anergy in some cases (Sloan-Lancaster et 
al., 1994; Madrenas et al., 1995; Kersh et al., 1998b). Hypophosphorylation of CD3ȗ and 
alternative signaling mechanisms are addressed in paper II. 
3.6. LAT and downstream signaling 
Activated CD3-bound ZAP-70 maintains the 
tyrosine phosphorylation cascade by 
phosphorylating LAT (Zhang et al., 1998; 
Weber et al., 1998) and SLP-76 (Wardenburg 
et al., 1996). LAT is a transmembrane protein 
which concentrates in lipid rafts (Lin et al., 
1999). It contains ten pY residues, where 
Y127, Y132, Y171 Y191 and Y226 (human 
sequence) are the most important (Zhang et 
al., 2000; Sommers et al., 2001; Paz et al., 
2001; Lin and Weiss, 2001). LAT serves as a 
docking site to which a number of adapter and 
signaling molecules bind through SH2 
domains (Grb2, Gads, PLCȖ1 and PI3K), or 
indirectly via adapters (SLP-76, Vav-1, SOS and Itk) (Zhang et al., 1998; Finco et al., 1998; 
Zhang et al., 1999a; Liu et al., 1999; Shan and Wange, 1999; Zhang et al., 2000; Bunnell et 
Figure 4. LAT signaling 
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al., 2000;  Ching et al., 2000; Paz et al., 2001; Lin and Weiss, 2001) (See Fig. 4). LAT is 
essential for TCR signaling as LAT-deficient mice have a block in thymocyte development 
at the immature stage and completely lack mature peripheral T cells (Finco et al., 1998; 
Zhang et al., 1999). SLP-76 is of particular importance for the LAT signaling scaffold. It 
binds LAT through Gads and is phosphorylated by ZAP-70 (Wardenburg et al., 1996). 
Phosphorylated SLP-76 provides binding for the Tec family kinase Itk which is imperative 
for full PLC Ȗ1 activation (Yablonski et al., 1998; Irvin et al., 2000; Bogin et al., 2007). As 
such, from SLP-76 and Itk knockout mice have similar phenotypes, and display disturbed 
PLCȖ1 activity, Ca2+ mobilization and IL-2 production (Liao and Littman, 1995; Clements 
et al., 1998; Pivniouk et al., 1998). Fully activated PLCȖ1 (pY783) catalyses the formation 
of IP3 and DAG (Downward et al., 1990), where the former leads to intracellular Ca2+
influx, and the latter recruits conventional and novel PKCs and RasGRP. RasGRP and SOS 
are guanine nucleotide exchange factors (GEFs), and catalyse the binding of GTP on the 
small G protein Ras. RasGRP has been shown to be the most important GEF in T cells 
(Ebinu et al., 2000; Priatel et al., 2002; Roose et al., 2005), although Grb2-SOS has also 
been implicated (Ravichandran et al., 1993), and especially upon partial agonist stimulation 
(Chau and Madrenas, 1999). Recent data indicate interplay between SOS1 and RasGRP in T 
cell Ras activation (Roose et al., 2007). Ras-GTP activates Raf-1, which phoshorylates 
MEK, leading to ERK phosphorylation. Phosphorylated ERK in turn activates c-Fos and c-
Jun which constitute the AP-1 transcription factor dimer (Su and Karin, 1996). The novel 
type calcium-independent PKCș is critical in the activation of NFțB in T cells (Sun et al., 
2000). PKCș is unique in its ability to localize to the supramolecular activation clusters of 
the TCR/CD3 complex (Monks et al., 1997; Monks et al., 1998). where it is phosphorylated 
and activated by Lck (Liu et al., 2000). Once active, PKCș activates IkB kinase (IKK) 
(Coudronniere et al., 2000, Lin et al., 2000), through the phosphorylation of CARMA1 
(Sommer et al., 2005; Matsumoto et al., 2005) and recruitment of the Bcl10–MALT1 
complex. Activated IKK phosphorylates IțB (Brown et al., 1995; Traenckner et al., 1995), 
marking it for ubiquitination and proteosomal degradation (Chen et al., 1995; Scherer et al., 
1995). When released from inhibition by  IțB, the transcription factor NFțB is free to 
translocate into the nucleus (May and Ghosh, 1998). On the other hand, the transcription 
factor NFAT translocates to the nucleus upon dephosphorylation by Calcineurin, a 
phosphatase activated by Ca2+ bound to calmodulin (Jain et al., 1993; Aramburu et al. 1998; 
Peng et al. 2001). NFAT, AP-1 and NFțB promote the transcription of a number of genes, 
most importantly IL-2, a cytokine which promotes long term proliferation of activated T 
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cells (Zhang and Nabel, 1994). Signal transduction from the TCR and CD28 also lead to 
cytoskeletal rearrangements, involving proteins such as Vav1, Cdc42, Rac-1 and WASP 
(Stowers et al., 1995; Holsinger et al., 1998; Sedwick et al., 1999; Snapper and Rosen, 
1999). These rearrangements are important for integrin signaling and formation of the 
immunological synapse.
3.7. Lck and inhibition of T cell signaling 
Figure 5. Negative regulation  of 
TCR signaling through Lck 
Interestingly, Lck has also been linked to negative 
regulation of TCR signaling (fig. 5). Some early 
reports suggested that the kinase function of Lck 
was not required for CD4-dependent T cell 
activation (Collins and Burakoff, 1993) or that 
deletion of the kinase domain even lead to 
hyperactivity (Xu and Littman, 1993). Engagement 
of the TCR with antagonists increased the activity 
of CD4-associated Lck without leading to T cell 
activation (Racioppi et al., 1996; Haughn et al., 
1992). Such T cells become anergic, and this indicates a negative role for Lck. Interestingly, 
it has been shown that triggering of the T cell antigen receptor by superantigens, such as 
staphylococcal enterotoxins, occurs independently of Lck (Yamasaki et al., 1997). In fact, 
JCaM1 cells lacking Lck, or human T cells pretreated with the PP2, are strongly 
hyperresponsive to SEE stimulation (Criado and Madrenas, 2004). This reveals a negative 
contribution of Lck to T cell activation, an effect that is dependent on its kinase activity. It 
was recently shown that superantigen triggering of the TCR activated  PLCȕ in a GĮ11-
dependent manner, and this resulted in robust ERK1/2 activation in Lck-deficient cells 
(Bueno et al., 2006). Other examples of Lck-independent signaling and negative regulation 
can also be found in the literature. For example, inhibition of Lck by antisense RNA in Th2 
cells leads to elevated levels of lymphokine mRNAs, including IL-4, IL-5, and IL-10, and 
these cells were capable of secreting IL-4 upon activation through the TCR (Al-Ramadi et 
al., 1996). This occured despite abolished phosphorylation of CD3ȗ and ZAP-70 and 
defective Ca2+ mobilization to antigenic stimuli. These data indicate that Lck-independent 
pathways of gene induction exist, a concept which we explored further in papers I and II. 
The negative role implicated for Lck is emphasized by its involvement in ligand-induced 
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TCR internalization (Luton et al., 1994; D’Oro et al., 1997; Lee et al., 1997; Salio et al., 
1997) and activation-induced cell death (Yu et al., 2004).  These data suggest that Lck may 
be important for regulating the availability of TCR and the magnitude of T cell signaling. 
Apoptotic pathways are also dependent on Lck (see chapter 3.7.5.). In paper III we 
investigated TCR turnover in T cells with low levels of Lck. 
3.7.1. Negative regulators of TCR signaling 
Inhibitory signaling is an important aspect of TCR signaling. In resting cells, inhibitory 
mechanisms keep the cell at rest, preventing aberrant immune activation. When the TCR of 
primary T cells is engaged without the secondary CD28 signal, negative feedback 
mechanisms trigger pathways rendering the cell anergic. T cells undergoing thymic 
education become apoptotic if triggered by autoantigens (clonal deletion). T cells react 
differently depending on the strength and duration of TCR engangement, or to paracrine 
cytokines and cell-cell contacts with other immune cells. A balance of activating and 
inhibiting pathways are important for this fine tuning of T cell responses. The tyrosine 
phosphorylation cascade outlined in chapters 3.3-3.6 reaches its peak after about 2-3 
minutes of TCR/CD3 stimulation. Likewise, the MAP kinases ERK1/2 reach their 
maximum phoshorylation within 3 minutes. After this peak most phosphorylation levels 
decline rapidly through the action of phosphatases and protein degradation, and are down to 
basal after about 30 minutes of TCR stimulation. Failures in these inhibitory mechanisms 
may lead to aberrant T cell responses, facilitating autoimmune diseases or cancer 
developement. 
3.7.2. SHP-1 
The function of the tyrosine phosphatase SHP-1 is an instructive example of negative T cell 
signaling (reviewed in Zhang J. et al., 2000). It is expressed at high levels in hematopoietic 
cells of all lineages, and altered expression and/or structure of SHP-1 plays a role in the 
progress of many forms of leukemia. Thymocytes from moth-eaten mice with reduced 
levels of SHP-1 show increased activation of Lck and Fyn, and develop a severe 
autoimmune and immunodeficiency syndrome with hyperactive T cells (Lorenz et al., 
1996). SHP-1 is activated by engagement of its tandem SH2 domains by phosphotyrosines 
(Pei et al., 1994), and Lck-mediated phosphorylation of Y536 and Y564 (Lorentz et al., 
1994, Frank et al., 2004). SHP-1 in turn serves to deactivate Lck by dephosphorylating 
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Y394 (Chiang et al., 2001), and also dephosphorylates other effectors of T cell signaling
such as ZAP-70 (Plas et al., 1996, Brockdorff et al., 1999), Vav1 (Pani et al., 1996; Kon-
Kozlowski et al., 1996),  SLP-76 (Binstadt et al., 1998) and CD3ȗ (Sozio et al. 2004). 
Furthermore, SHP-1 participates in fine tuning of TCR signals, as demonstrated by low 
affinity ligands which trigger binding of the SHP-1 to Lck. This negative feedback is 
circumvented by stronger ligands through phosphorylation of S59 in Lck in an ERK-
dependent manner, which prevents SHP-1 binding and inhibition (Stefanova et al., 2003). 
The impact of Lck-kd on SHP-1 activity was addressed in Paper I. 
3.7.3. Ras-GAP 
The Ras GTPase p120 Ras-GAP is a negative regulator of Ras signaling acting by 
accelerating the hydrolysis of Ras-GTP to Ras-GDP. Ras-GAP is thought to be activated by 
membrane recruitment and tyrosine phosphorylation on several residues, most importantly 
Y460 (Liu and Pawson, 1991; Amrein et al., 1992, Park et al., 1993). There has been some 
controversy regarding the effects of Ras-GAP phosphorylation by Lck (Amrein et al., 1994, 
Giglione et al., 2001). Recently it was shown that Ras-GAP interacts with Cbp/PAG in 
stimulated T cells, suppressing Ras activation (Smida et al., 2007). This effect was shown to 
be independent of Csk binding. The phosphorylation and recruitment of Ras-GAP in the 
context of Lck knockdown was investigated in Paper II. 
3.7.4. Cbl 
The E3 ubiquitin ligase Cbl functions as a negative regulator of many signaling pathways. 
Cbl exists in two main isoforms, c-Cbl and Cbl-b, with a high level of sequence 
conservation. c-Cbl is activated by tyrosine phosphorylation on several residues, most 
importantly Y700, Y731 and Y774 (Hunter et al., 1999; Donovan et al., 1994; Feshchenko 
et al., 1998; Kassenbrock and Anderson, 2004). These residues are not, however, substrates 
of Lck or ZAP-70, but of Fyn and Syk (Hunter et al., 1999; Feshchenko et al., 1998; 
Tsygankov et al., 1996; Deckert et al., 1998), which are activated directly or indirectly by 
Lck (Filipp et al., 2003). Engagement of the TCR leads to activation of T cells, but also 
internalization and lysosomal degradation of the receptor complex (Valitutti et al., 1997). 
This serves to terminate signaling, and this process is dependent on the tyrosine kinase 
activity of Lck (Luton et al., 1994; D’Oro et al., 1997) and ubiquitination by c-Cbl (Hou et 
al., 1994; Cenciarelli et al., 1996; Wang et al., 2001, Naramura et al., 2002). Ubiquitination 
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marks active enzymes and receptors for degradation (reviewed in Thien and Langdon, 2005 
and Swaminathan and Tsygankov, 2006). Cbl-dependent ubiquitination requires interaction 
with the target protein. For example, c-Cbl and Lck interact through binding of proline-rich 
seqences in Cbl with the SH3 domain in Lck. The SH2 domain of Lck also binds to 
phosphorylated sites in Cbl, and the Cbl TKB domain binds to the activation loop 
phosphorylation site in Lck after stimulation of T cells (Rao et al., 2002). Other notable 
targets for c-Cbl-mediated ubiquitination are Vav (Miura-Shimura et al., 2003), Fyn 
(Yokouchi et al., 2001; Andoniou et al., 2000; Hunter et al., 1999), ZAP-70 (Lupher et al., 
1996), as well as the already mentioned TCR/CD3-complex. Consistent with the negative 
regulation assigned to the Cbl family of proteins, T cells from c-Cbl-/- and Cbl-b-/- mice were 
hyperactive upon TCR engagement, although some biochemical distinctions between the 
phenotypes existed (Murphy et al., 1998; Naramura et al., 1998; Thien et al., 1998; 
Bachmaier et al., 2000; Chiang et al., 2000). T cells from double-knockout (dKO) mice 
lacking both c-Cbl and Cbl-b, failed to modulate surface TCR after ligand engagement, 
resulting in sustained TCR signaling and ERK1/2 phosphorylation. However, signaling 
through the major TCR pathways were not increased (Naramura et al., 2002). The impact of 
reduced Lck levels on c-Cbl activity and TCR/CD3 turnover was investigated further in 
Paper III. 
3.7.5. Bak 
Bak is a pro-apoptotic member of the Bcl-2 family of proteins, and participates in the 
mitochondrial pathway of apoptosis. JCaM1 cells were shown to completely lack Bak, an 
effect that was reversed upon reconstitution with Lck (Samraj et al., 2006). This and other 
studies have shown that T cells lacking Lck are resistant to apoptosis induced by many 
kinds of stimuli (Di Somma et al., 1995; Oyaizu et al., 1995; Belka et al., 2003; Hur et al., 
2004; Gruber et al., 2004). Interestingly, the effect of Lck on Bak transcription was 
independent of the kinase domain of Lck and classical mediators of T-cell signaling such as 
ZAP-70 and LAT (Samraj et al., 2006). Most research regarding Lck has focused on its 
capacity as a tyrosine kinase, but these data indicate that Lck also participates in other kinds 
of signaling, where the presence of Lck is required for the transcription of other proteins. 
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3.8. Heterotrimeric G proteins and T cell signaling 
Heterotrimeric G proteins consist of an Į-subunit that binds and hydrolyzes GTP, and ȕ- and 
Ȗ-subunits that form an undissociable ȕȖ-complex. Coupling between an activated G-
protein-coupled receptor (GPCR) and its G protein promotes the exchange of GDP for GTP 
on the Į-subunit. This allows the Į-subunit and the ȕȖ-complex to dissociate and modulate 
the activity of a variety of effectors such as ion channels and enzymes (reviewed in 
Offermanns, 2000). T cells express most GĮ-subunits of the GĮs, GĮi, GĮq/o and GĮ12
families (Offermanns et al., 2001), and heterotrimeric G proteins have been implicated in T 
cell signaling in several reports (Cenciarelli et al., 1992; Sancho  et al., 1993; Stanners et al., 
1995; Zhou et al., 1998; Tsoukas et al., 2000; Lippert et al., 2000). For example, it has been 
shown that activation of primary T cells lead to recruitment of GĮs and GĮq to lipid rafts 
(Abrahamsen et al., 2004), and crosstalk between heterotrimeric G-proteins and different 
tyrosine kinases has been reported in several cell types (Luttrell et al., 1996; Luttrell et al., 
1997; Luttrel et al., 1999; Luttrell et al., 2004). Src can be activated directly by GĮs or GĮi
through binding binding of the G protein to the catalytic domain of Src (Ma et al., 2000), 
and Lck can also be regulated positively by the same GĮs-dependent mechanism (Gu et al., 
2000). Cross-talk between the GĮq and Lck has been reported (Inngjerdingen et al. et al., 
2002). Transfection with a function deficient mutant of GĮq/11 impared phosphorylation of 
CD3ȗ and ZAP-70 (Stanners et al. 1995). A recent report shows that JCaM1 cells lacking 
Lck may be activated through a GĮ11-dependent mechanism, mediated through PLCȕ1
activation (Bueno et al., 2006). The involvement of G proteins in T cell signaling and the 
interplay between G proteins and Lck was explored in paper IV. 
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4. Aims of the present study 
In this thesis we wanted to investigate the molecular mechanisms responsible for regulation 
of TCR-induced signaling mediated through the Src kinases Lck and Fyn, and the 
heterotrimeric G proteins GĮs, GĮi-2 and GĮq.
The main objectives of the present study were to: 
1.   Generate siRNAs for the SFKs Lck and Fyn, as well as the heterotrimeric G proteins 
GĮs, GĮi-2 and GĮq, and validate these siRNAs with respect to potency and specificity in 
both Jurkat and primary human T cells. 
2.   Explore the impact of Lck knockdown in T cells, and hereunder: 
a) Characterize the observed paradoxical hyperresponsive Lck-kd phenotype using 
standard biochemical assays. 
b) Investigate possible alternative mechanisms of T cell activation. 
c) Study the involvement of Lck in negative T cell signaling. 
3.   Investigate the involvement of heterotrimeric G proteins in T cell signaling, with 
particular emphasis on their possible crosstalk with Lck. 
29
5. Synopsis of papers 
Paper I: 
Short-interfering RNA-mediated Lck knockdown results in augmented downstream T 
cell responses. Here, we designed, synthesized and validated four siRNAs and one control 
siRNA for Lck and Fyn respectively. We obtained highly efficient knockdown in both 
Jurkat and primary human T cells using low doses of siRNA (100 nM). By using other 
siRNAs we controlled for off-target effects. As expected, proximal signaling was reduced 
with Lck-kd as determined by overall tyrosine phosphorylation, CD3ȗ phosphorylation and 
Ca2+ mobilization. Surprisingly, we observed augmented activation of NFAT-AP-1 and 
sustained phosphorylation of ERK1/2 in Jurkat cells, and increased secretion of IL-2 in 
primary T cells. We found that the phosphatase activity of SHP-1 was reduced in Lck-kd 
cells, and we speculated whether alternative mechanisms of activation could be in operation, 
possible mediated through ERK as we observed sustained phosphorylation of this MAPK. 
Fyn did not seem to be responsible for this mechanism since co-knockdown of Fyn did not 
reverse hyperresponsiveness in Lck-kd cells. 
Paper II: 
Hypophosphorylated TCR/CD3-zeta signals through a Grb2-SOS1-Ras pathway in 
Lck knockdown cells. In this study we presented an alternative mechanism of TCR 
signaling in T cells with Lck-kd. We reported the recruitment of Grb2-SOS1 to CD3ȗ after 
prolonged stimulation of Lck-kd cells. In line with this, Ras, Raf-1 and ERK1/2 displayed 
sustained activation. In a solid phase assay, Grb2 bound to incompletely phosphorylated 
ITAM1 with the pY-Y configuration, but was competed by ZAP-70 with respect to binding 
to the doubly phosphorylated pY-pY conformation of the ITAMs. We also found that the 
phosphorylation of Ras-GAP was strongly suppressed in Lck knockdown cells, indicating 
that a Ras negative feedback mechanism is dependent on Lck. 
Paper III: 
Normal TCR/CD3 endocytosis but reduced CD3-zeta degradation despite diminished 
Cbl phosphorylation in T cells with low Lck levels. In this report we investigated further 
how low levels of Lck may result in aberrant T cell signaling. c-Cbl phosphorylation was 
strongly reduced in T cells with Lck knockdown, as was ubiquitination of CD3ȗ.
Surprisingly, endocytosis of the T cell receptor complex occured normally, but confocal 
microscopy showed that CD3ȗ containing vesicles were not targeted for lysosomal 
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degradation to the same degree as in control cells. This led to reduced degradation of CD3ȗ,
and we hypothesized that prolonged cytosolic subsistence of the T cell receptor complex 
could result in extended signaling in T cells with Lck knockdown. 
Paper IV: 
GĮq regulates TCR-mediated immune response in T cells through an Lck-dependent 
pathway. In this paper we showed that GĮs and and GĮq, but not GĮi-2 were activated 
upon anti-CD3 stimulation, and we targeted GĮs, GĮi-2 and GĮq with siRNA-mediated 
knockdown to examine their roles in TCR sigaling. GĮs-kd and GĮi-2-kd did not result in 
any significant changes, but GĮq-kd reduced Lck activity significantly. Despite this, NFAT-
AP-1 and ERK1/2 phosphorylation were augmented. Similarly, primary T cells from GĮq-/-
mice displayed reduced proximal signaling, but augmented secretion of IL-2, IL-5, IL-12 
and TNF-Į. The hyperresponsivenss in GĮq-kd cells was reversible when cells were 
transfected with constitutively active Lck Y505F or pretreated with PP2. We speculated that 
GĮq has a key regulatory role in T cell signaling acting at the level of Lck. 
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6. Discussion 
6.1. The Lck knockdown phenotype 
6.1.1. Low levels of Lck and alternative signaling mechanisms 
Recruitment of other proteins than ZAP-70 to hypophosphorylated CD3ȗ ITAMs has been 
suggested previously, but not in the context of Lck knockdown. (Ravichandran et al., 1993, 
Osman et al., 1995, Nel et al., 1995, Labadia et al., 1996, Zenner et al., 1996, Chau et al., 
1999). Chau and Madrenas (1999) proposed that partial agonists may trigger Grb2-SOS 
binding to hypophosphorylated CD3ȗ in the absence of LAT phosphorylation. Similarly, we 
propose that low levels of Lck may give rise to hyperresponsive signaling through CD3ȗ-
Grb2-SOS1 when negative feedback through SHP-1, Ras-GAP and c-Cbl is displaced 
(Paper I-III). An important question is why T cells treated with pharmacological inhibitors 
to Lck such as PP2, or cells overexpressing Csk, do not display a similar hyperactivity in 
response to anti-CD3 ligation. Such treatments also reduce the kinase activity of Lck, but 
they do not result in an hyperactive response as described for Lck-kd.
It is becoming clear that Lck does not function exclusively as a tyrosine kinase. Lck is also 
an important adapter protein, and participates in signaling pathways not directly related to 
the TCR. It was recently reported that the transcriptional activation of the pro-apoptotic 
protein Bak was dependent on Lck (Samraj et al., 2006). The authors concluded that this 
effect was independent of the kinase domain of Lck, PP2 treatment, and classical mediators 
of T-cell signaling such as ZAP-70 and LAT. How Lck confers its influence on Bak 
expression remains undetermined. In another report, JCaM1 cells expressing a mutated form 
of Lck lacking the SH3 domain, failed to activate ERK1/2 despite normal TCR  chain 
phosphorylation, ZAP-70 recruitment, and ZAP-70 activation (Denny et al., 1999). In 
contrast, we show that ERK1/2 becomes activated despite reduced TCRȗ phosphorylation 
and ZAP-70 activation (Papers I and II). These results suggest that Lck participates in more 
than one signaling pathway, and that removal of Lck, or parts of Lck, may result in different 
outcomes than mere inhibition of the protein. This notion is of interest in T cells since most 
of the research conducted on Lck has focused on its capacity as a tyrosine kinase. The 
siRNA-mediated Lck-kd phenotype we have investigated is paradoxical in this respect, and 
alludes to alternative or complementary signaling mechanisms. Whether or not such 
responses are aberrant or physiologically relevant is not known. Acute knockdown of a 
protein is unlikely to occur in a physiological setting. T cells with reduced levels of Lck 
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have been reported from humans in the literature, but these patients have endured long 
lasting lack of Lck activity. The pathologies implicated ranged from immunodeficiency 
(CVID, SCID) to autoimmunity (lupus, diabetes, reumatoid arthritis). Common for most, 
but not all of these cases, was reduced proximal T cell signaling. In some cases, various 
forms of activity was observed, although not hyperresponsiveness as we report. It is 
therefore possible that siRNA-mediated knockdown of Lck results in an experimentally 
induced artificial phenotype. What is interesting, however, is that we have detected an 
alternative signaling mechanism, which may be important for signaling in T cells in other 
contexts. In the study published by Lovatt et al., low levels of Lck produced the same 
degree of MEK and ERK1/2 phosphorylation as Lck-deficient cells. This effect was shown 
to be dependent on Fyn, and they speculated that SOS could be involved in producing Ras 
activation (Lovatt et al., 2006). Clearly, such a notion is interesting in respect to the data 
presented in Paper II. In the classical paradigm of T cell activation, Lck is the exclusive 
conveyer of signal transmission mediated through the TCR. In this framework, Lck is 
activated by TCR engagement and its primary function is to phosphorylate the TCR/CD3-
complex. Genetic, mutational and pharmacological data assembled from fifteen years of 
research indicate that Lck plays an important role, but it is not indispensable for T cell 
signaling, and Lck also participates in negative regulation. Lck-independent signaling 
mechanisms have been shown especially for partial agonist effects (Yamasaki et al., 1997; 
Chau and Madrenas, 1999; Criado and Madrenas, 2004; Bueno et al., 2006). It has also been 
shown that defective Ca2+ signaling blocks NFAT1 translocation, while selectively 
activating NFAT2 in anergic T cells (Srinivasan and Frauwirth, 2007). The field now 
increasingly acknowledges the non-linear dynamics of cellular systems, with increasing 
focus on differential signaling mechanisms, and the more complex role of signal transducers 
such as Lck. 
6.1.2. Lck and apoptosis 
Since Lck has been implicated in apoptosis and activation induced cell death (AICD), we 
hypothesized that reduced apoptosis and/or AICD, could contribute to sustained signaling i 
T cells with low levels of Lck. However, during the course of the experiments conducted in 
Jurkat TAg cells (6 h for the NFAT-AP-1-luciferase assay), no induction of  apoptosis or 
reduction of cell viability was observed after OKT3 stimulation, even with low or high 
dosages (TM, unpublished observations). This was surprising as we found Bak expression 
33
to be severely affected by Lck 
knockdown (Fig. 6), in agreement with 
the report by Samraj et al. (2006). 
Activation of Caspase-3 was even 
reduced upon OKT3-stimulation in both 
control and Lck-kd cells, and there was no 
difference in Caspase-3 activation in the 
positive control (FasL treatment) (TM, 
unpublished observations). 
Figure 6. Bak expression in Lck-kd cells 
6.1.3. Endocytosis of TCR/CD3 
As reported in Paper III, we observed no difference in endocytosis of engaged TCR/CD3-
complex in control and Lck-kd cells. This was surprising as previous reports had indicated 
this process to depend on Lck and/or Cbl-mediated ubiquitination for this process to occur 
(Luton et al., 1994, D’Oro et al., 1997, Hou et al., 1994, Cenciarelli et al., 1996, Wang et al., 
2001, Naramura et al., 2002). Seemingly, endocytosis can take place with very low Lck 
and/or Cbl activity, or other mechanisms are involved. The latter scenario seems plausible 
as internalization of the TCR/CD3-complex was completely unaffected by the loss of Lck. 
However, we did observe a significant reduction in lysosomal sorting of CD3-containing 
vesicles in the Lck-kd cells. This suggests that Cbl-mediated ubiquitinylation is required for 
this process, but is dispensable for endocytosis of the TCR. Similar data have been reported 
for the EGF receptor (Duan et al., 2003, Padrón et al., 2007).  
6.2. The involvement of heterotrimeric G proteins in T cell signaling 
As shown in paper IV, triggering of the TCR leads to GTP-binding and thus activation of 
GĮq. The mechanism whereby this occurs is unknown, but probably involves the 
recruitment of a GEF for heterotrimeric G proteins to the membrane, or cross-talk between 
the TCR and a GPCR, perhaps CXCR4 (Peacock and Jirik 1999; Kumar et al., 2006; 
Patrussi et al., 2007). Knockdown of GĮq inhibited Lck autophosphorylation, whereas 
overexpression of a constitutively active mutant of GĮq augmented Lck activity. These data 
alludes to some kind of interplay beween Lck and GĮq, which has been shown previously 
for GĮs and Lck (Gu et al. 2000). Surprisingly, GĮq-kd and GĮq KO augmented 
downstream T cell responses, despite reduced proximal signaling. This effect was reversed 
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to basal levels by PP2, and to the level of stimulated control cells by co-transfection with 
Lck Y505F. This indicates that both reduction and overexpression of GĮq may produce 
Lck-dependent hyperactivity. Furthermore, since Lck Y505 reduced the response in GĮq-kd
cells, but augmented signaling in unstimulated cells, it is likely that Lck contributes both 
negatively and positively to T cell activation. We postulate that TCR stimulation activates 
GĮq which augments Lck activity, whereas GĮq-kd inhibits Lck activity and results in 
signaling through other pathways. 
6.3. Methodological considerations 
6.3.1. siRNA-mediated RNAi 
A publication in 1990 triggered the discussion of co-suppression of endogenous genes by 
transgenes: Overexpression of chalcone synthase, which is responsible for violet coloration 
in petunias, rendered the petunia flowers white (Napoli et al., 1990). dsRNA-mediated gene 
silencing of target mRNA was documented in C.elegans eight years later (Fire et al., 1998), 
a work for which the principal investigators Andrew Fire and Craig Mello received the 
Nobel Prize in 2006. This method has since been employed with success in mammalian 
cells (Elbashir et al., 2001), and T lymphocytes (McManus et al., 2002a, McManus et al., 
2002b), and is now routinely used in biomedical research. Per october 2007, a PubMed 
search returns more than 12.800 hits for “siRNA”. 
The siRNAs used in this thesis are 21-nt duplex oligomers with a 2-nt overhang on each 
end. They were designed and synthesized in-house based on an in-house developed 
algorithm by Amarzguioui et al., (2004). The utility of the RNAi approach depends on 
target specificity and side effects of the treatment. For example, indifferent design or 
secondary RNA structures may cause off-target down regulation of other genes (Bridge et 
al., 2003). siRNAs utilize a molecular machinery already present in the cell, that probably 
evolved to combat RNA viruses. The complete effects of this system, appart from mRNA 
clevage, are still not known in full detail. When introduced into mammalian cells, long 
dsRNAs are fragmented by the protein Dicer. The shorter pieces are used as templates by 
RNA induced silencing complex (RISC) to cleave any complementary RNA sequence in the 
cell, thus disrupting protein translation. However, virus-infected cells may also trigger a 
PKR-interferon response when exposed to dsRNA. This shuts down all protein production 
and induces the production of INFȖ, a cytokine which activates cytotoxic immune cells. 
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This classical anti-viral defence is instigated to avoid transcription of viral proteins and to 
ensure elimination of infected cells. siRNAs are thought to be short enough to evade the 
PKR-interferone effects in vertebrates, but 21-nt siRNAs have been shown to activate these 
mechanisms in a concentration-dependent manner in vitro (Sledz et al., 2003). Such 
problems must be considered whenever using siRNAs, and they must be controlled for as 
thoroughly as possible in biomedical research. The siRNAs used in this thesis were 
examined and validated by the following means: 
1.) All siRNA seqences were blasted towards the human genome to avoid overlap 
with other proteins. 
2.) Control siRNAs were designed for all siRNAs employed. The control siRNAs 
contain a triple G/C switch, and were tested with standard biochemical assays 
(monitoring of NFAT-AP-1 reporter assay, and ERK1/2 phosphorylation), against 
mock transfected cells and another control siRNA (Csk2033M3), to ensure that they 
did not significantly influenced signaling. 
3.) Knockdown cells were compared to control transfected cells in all experiments, 
thus ensuring that introduction of siRNAs per se does not generate unwanted side 
effects.
4.) Dosage and incubation time were optimized for each siRNA to ensure minimum 
RNA load in each cell. For Lck232 and Fyn1059, 100 nM of siRNA and 48 hours of 
incubation post transfection was found to produce optimal knockdown. For 
knockdown of G-proteins, 400 nM siRNA was used. Compared to other studies, both 
100 nM and 400 nM are low (Peter et al., 2007) when taking into account 
transfection efficiency in electroporation and nucleofection used on T cells. This 
indicates high potency of the designed siRNAs.
5.) We monitored several other proteins to verify that knockdown was specific. For 
Lck-kd, the expression of Fyn, Csk, PKCĮ, PLCȖ1, LAT, FAK and Pyk2 was not 
disturbed in siRNA concentrations up to 1500 nM, which was the maximum tested. 
6.) For Lck-kd and GĮq-kd, another siRNA was used to reproduce the main findings. 
No difference in results between the different siRNAs was found, thus minimizing 
the risk of observations being influenced by off-target effects due to secondary 
structures.
7.) For Lck-kd we also performed a selection experiment. Cells were co-transfected 
with a surface marker, and positive cells were selected from control and Lck 
knockdown populations for NFAT-AP-1 luciferase reporter assays. Selected cells 
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were compared to control and negatively selected cells, but no difference in relative 
signaling between Lck knockdown and control cells was observed. As expected, the 
absolute luciferase numbers were higher in the selected population as they contained 
more NFAT-AP-1 cDNA. However, since transfection with siRNAs are about 3-fold 
more efficient than cDNA transfections, and knockdown efficiency is so high, the 
selected cells behaved essentially as the whole cell population, and indeed, the 
knockdown of Lck was similar between the two groups (Paper I). 
8.) We also transfected cells and monitored them for several days. The 
hyperresponsive effect seen in Lck-kd cells was induced upon protein knockdown 
and was completely reversible when protein levels returned to normal, 
approximately 7-9 days post-transfection (Paper III). 
Based on these assays, we propose that the siRNAs used in our studies are properly 
validated, and that the results obtained are primarily due to knockdown of specific proteins, 
not unwanted side effects. Given these premises, siRNA-induced gene silencing have many 
advantages over gene knockout by homologous recombination. Firstly, it is a faster and 
cheaper method, and one can relatively easily knock down more than one protein 
simulatneously. Secondly, the method gives acute knockdown in mature human cells. The 
last point is important as it opposes to knockout animals who may suffer embryonic lethality 
or long term defects from their knockouts. For example, compensatory mechanisms may 
develop over time. The siRNAs used in this thesis have provided potent knockdown 
consistently, and the cells could be used in experiments just 48 h after transfection.  
   This does not preclude that other problems might arise with siRNA induced gene 
silencing. An important factor is that ranges of knockdown are obtained. Since we operated 
with knockdown efficiencies close to 100% this factor is minimized, but it is still possible to 
envision the potential problem: In principle, if western blotting of whole cell lysates show 
90% knockdown of a protein, one can not be sure whether 100% of the cells have 90% 
protein knockdown, or 90% of the cells have 100% knockdown. The most plausible 
scenario is a range of knockdowns ranging from 0% in untransfected cells and close to 
100% in cells with high transfection efficiency. Most biochemical assays are conducted on 
whole cell populations, and effects from certain levels of knockdown may dominate the 
final result. For example, it is possible that certain ranges of Lck knockdown produce 
hyperactive responses, while untransfected cells behave as normal cells, and some cells with 
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very high knockdown are nonresponsive. The end result may indicate augmented signaling, 
even though this is not true for all the cells in the experiment.  
6.3.2. The Jurkat cell model 
In immunology, the Jurkat T cell line (Weiss et al.,  1984) has been used along side other T 
cell lines and primary T cells from mice and humans, as model systems for investigation of 
T cell signaling. A large body of research using both Jurkat cell lines and primary T cells, 
has demonstrated the crucial role of Lck in T cell development and TCR signaling. It is 
therefore surprising to note that Jurkat TAg T cells with siRNA mediated Lck knockdown 
display hyperresponsiveness.  Jurkat TAg T cells are Jurkat E6.1 cells stably transfected 
with Simian virus 40 (SV40) large T antigen (TAg). The complete nature of  SV40 
oncogenic cellular transformation is not completely understood, but it involves the 
manipulation of tumor suppressors and cell cycle regulatory proteins such as the 
retinoblastoma family of proteins, p53 and the transcriptional co-activators p300 and CBP 
(reviewed in Ali et al., 2001). Jurkat TAg and E6.1 cells are thought of as identical in regard 
to TCR signaling characteristics, but TAg cells are more viable and easier to transfect. As a 
control, knockdown of Lck was conducted in Jurkat TAg and E6.1 cells in parallell, and 
NFAT-AP-1 activation was monitored. Surprisingly, Jurkat E6.1 Lck-kd cells were 
completely non-responsive to anti-CD3 ligation, wheras Jurkat TAg Lck-kd cells were 
hyperresponsive (Fig. 7). These conflicting data are not unique to Jurkat cells. A similar 
scenario was reported for HEK293 cells by Lefkowitz et al. in 2002, in which the Ptx-
sensitivity to ȕ-adrenergic ERK1/2 activation was 
shown to vary from 0 to 100% in cell lines 
obtained from various sources (Lefkowitz et al. 
2002). How is it possible that Jurkat TAg cells 
and Jurkat E6.1 cells with Lck-kd give rise to 
completely different phenotypes? Based on data 
from primary human T cells where observations 
are similar to those in obtained in Jurkat TAg we 
have continued to investigate Lck knockdown in 
Jurkat TAg cells, but only reproduction of these 
results by other groups can validate our 
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Figure 7. Jurkat TAg vs Jurkat E6.1 
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differences over time, and batches of cells may vary from laboratory to laboratory. We have 
reproduced the results from Jurkat TAg cells with other sources to rule out specific 
disorders with our batch. Relative to other cell types, the Jurkat TAg and E6.1 cells are very 
similar, and the two cell lines have been used side by side in experiments for many years. 
This discrepancy warrants a discussion regarding the validity of cell lines, not only in T cell 
signaling, but also in experimental research generally. This also illustrates the necessity of 
validating observations from cell lines in primary human cells or mouse models. We have 
used primary human T cells in Papers I and II, and mouse T cells from knockout mice in 
Paper IV.
6.4. Future perspectives 
Many interesting questions were raised during the work on this thesis, and further 
investigation of complementary or alternative signaling mechanisms in T cells is of interest. 
It is becoming clear that the strictly linear signaling concept of the Lck-CD3-ZAP70-LAT 
pathway is an oversimplification. Various ligand affinities and durations of TCR, CD3, CD4 
and CD28 engagements, may produce different kinds of signaling. Within the Lck 
knockdown model, it would be interesting to monitor more closely differences in activation 
patterns for various of Lck protein levels. For example, it is possible to transfect T cells with 
siRNAs, withdraw cells after various periods of incubation, and analyse the status of many 
phosphoproteins by flow cytometry. By doing this, changes in signaling depending on 
reducing or increasing amounts of Lck can be observed with higher fidelity. 
Furthermore, since the expression of Bak is dependent on the presence of Lck, it would be 
interesting to perform microarray analysis of Lck-kd cells to monitor whether other proteins 
are affected. If other proteins are also regulated, it may bring new insight to the paradoxical 
hyperresponsive signaling we have observed in Lck-kd cells. The mechanism by which Lck 
controls the promoter activity and expression of other proteins is also of importance, since 
this opens up new a aspect of Lck-mediated signaling. 
In Paper III we reported that endocytosis of the TCR/CD3-complex occured normally 
despite reduced Lck and Cbl activity. Seemingly, internalization of the receptor was not 
dependent on Lck/Cbl, or very low levels of activity from these proteins was sufficient for 
this process to occur. Furthermore, even though reduced, colocalization of CD3-containing 
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vesicles with lysosomes was not completely abolished in Lck-kd cells, indicating that 
vesicles can merge with lysosomes independently of ubiquitination. Further investigation of 
the mechanism by which TCR/CD3 is endocytosed, and how these vesicles localize with 
lysosomes, is warranted. The Lck-kd model, and siRNA-mediated knockdown of other 
protens, can be used as a valuable tool for such experiments. For example, what phenotypes 
will knockdown of c-Cbl, or the concurrent knockdown of c-Cbl and Lck produce in this 
respect? 
The question of how the TCR activates GĮq, and how the activated subunit exerts its effect 
on Lck, and vice versa, will be interesting to pursue in future studies. Our data indicate that 
interplay between Lck and GĮq exist, and that they interact physically in T cells. 
Furthermore, signaling through, and crosstalk between TCR and CXCR4 would be 
interesting to investigate using siRNA-mediated knockdown of Lck and G-proteins. 
Finally, the striking difference in signaling observed in Jurkat TAg and Jurkat E6.1. cells 
with Lck-kd should be investigated further. That two similar cell lines can generate 
completely different phenotypes is disturbing, and this finding should be addressed more 
thoroughly in the wider scientific community. 
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7. Conclusions 
1. siRNA-mediated knockdown of the 
Src family kinase Lck, but not Fyn, 
renders T cells hyperresponsive.
2. An alternative signaling pathway is 
activated in T cells with low levels of 
Lck. Prolonged stimulation leads to 
recruitment of Grb2-SOS1 to 
hypophosphorylated CD3ȗ, resulting 
in signaling through Ras-Raf-1-MEK-
ERK.
3. Colocalization of CD3-containing 
vesicles with lysosomes is reduced in 
stimulated T cells with Lck 
knockdown, resulting in prolonged 
subsistence of CD3ȗ.
Figure 8. Alternative signaling pathway in T 
cells with siRNA-mediated Lck knockdown. 
4. Negative regulators of T cell signaling, such as SHP-1, Ras-GAP and Cbl display reduced 
activity in Lck-kd cells. We propose that sustained signaling from CD3ȗ-Grb2-SOS1-Ras-
ERK1/2 in the absence of the negative feedback constraints normally imposed by Lck, may 
result in hyperresponsiveness in T cells with siRNA-mediated Lck knockdown (Fig. 8). 
5. We report interplay between Lck and GĮq. GĮq appears to enhance Lck activation upon 
TCR triggering. Knockdown of GĮq renders T cells hyperresponsive possibly due to 
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